Literature DB >> 30240870

MIB Index as Predictor of Recurrence in Sporadic Vestibular Schwannomas.

Manas Panigrahi1, Dilip Kumar2, Sudhindra Vooturi3, Shailaja Madigubba4.   

Abstract

OBJECTIVE: Nearly 9.2% of vestibular schwannomas (VS) recur. We evaluate the association of cell proliferative markers like MIB with recurrence in VS.
METHODS: Retrospective data of 144 consecutive patients who underwent surgical excision for sporadic VS between January 2010 and July 2015 were collected. Comparison between groups based on recurrence of VS was done.
RESULTS: The average age of the study population was 43.95 ± 12.86 years with 77 (53.5%) men. The average maximal diameter of VS was 40.25 ± 7.23 mm. Gross total resection was done in 52 (36.1%) patients. While near total resection was performed in 81 (56.3%) patients, the remaining 11 (7.6%) patients underwent a subtotal resection. The mean follow-up period was 37.99 ± 10.09 months (24-60). Recurrence of VS was observed in 18 (12.5%) patients. There was no difference between the groups for diameter of the tumor (42.22 ± 8.04 vs. 39.64 ± 7.00 mm; P = 0.191). The average MIB index value was higher in patients with recurrence of tumor at follow-up (4.78 ± 5.77 vs. 1.89 ± 1.48 mm; P < 0.001). There was no difference between the groups for extent of resection or postoperative complications. MIB was the only significant predictor for recurrence (β = 1.355 (1.07-1.78; confidence interval 95%); P = 0.031). On receiver operating characteristic curves, a cutoff value of 3.5% for MIB showed a specificity of 84.1%.
CONCLUSIONS: MIB index ≥3.5% is associated with recurrence in VS. Maximal diameter of the tumor and extent of resection are perhaps not associated with recurrence of VS.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  MIB index; Recurrence; Sporadic vestibular schwannomas

Mesh:

Substances:

Year:  2018        PMID: 30240870     DOI: 10.1016/j.wneu.2018.09.039

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  6 in total

Review 1.  Evaluating growth trends of residual sporadic vestibular schwannomas: a systematic review and meta-analysis.

Authors:  Abdullah Egiz; Hritik Nautiyal; Andrew F Alalade; Nihal Gurusinghe; Gareth Roberts
Journal:  J Neurooncol       Date:  2022-06-27       Impact factor: 4.506

2.  A Nomogram to Predict Recurrence-Free Survival Following Surgery for Vestibular Schwannoma.

Authors:  Zehan Zhang; Ding Zhang; Xudong Shi; Bingyan Tao; Yuyang Liu; Jun Zhang
Journal:  Front Oncol       Date:  2022-04-28       Impact factor: 5.738

3.  Surgery After Surgery for Vestibular Schwannoma: A Case Series.

Authors:  Łukasz Przepiórka; Przemysław Kunert; Wiktoria Rutkowska; Tomasz Dziedzic; Andrzej Marchel
Journal:  Front Oncol       Date:  2020-12-18       Impact factor: 6.244

4.  Risk Factors for Progression in Vestibular Schwannomas After Incomplete Resection: A Single Center Retrospective Study.

Authors:  Jiuhong Li; Xueyun Deng; Daibo Ke; Jian Cheng; Si Zhang; Xuhui Hui
Journal:  Front Neurol       Date:  2021-11-26       Impact factor: 4.003

5.  The impact of the MIB-1 index on facial nerve outcomes in vestibular schwannoma surgery.

Authors:  Johannes Wach; Simon Brandecker; Agi Güresir; Patrick Schuss; Hartmut Vatter; Erdem Güresir
Journal:  Acta Neurochir (Wien)       Date:  2020-03-09       Impact factor: 2.216

6.  Quantitative Evaluation of Proliferative Potential Using Flow Cytometry Reveals Intratumoral Heterogeneity and Its Relevance to Tumor Characteristics in Vestibular Schwannomas.

Authors:  Soichi Oya; Shinsuke Yoshida; Shunya Hanakita; Mizuho Inoue
Journal:  Curr Oncol       Date:  2022-03-03       Impact factor: 3.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.